全文获取类型
收费全文 | 20618篇 |
免费 | 1567篇 |
国内免费 | 1071篇 |
出版年
2024年 | 33篇 |
2023年 | 207篇 |
2022年 | 517篇 |
2021年 | 924篇 |
2020年 | 615篇 |
2019年 | 754篇 |
2018年 | 850篇 |
2017年 | 574篇 |
2016年 | 873篇 |
2015年 | 1229篇 |
2014年 | 1405篇 |
2013年 | 1559篇 |
2012年 | 1896篇 |
2011年 | 1688篇 |
2010年 | 1063篇 |
2009年 | 915篇 |
2008年 | 1183篇 |
2007年 | 1027篇 |
2006年 | 889篇 |
2005年 | 796篇 |
2004年 | 657篇 |
2003年 | 592篇 |
2002年 | 521篇 |
2001年 | 369篇 |
2000年 | 303篇 |
1999年 | 297篇 |
1998年 | 194篇 |
1997年 | 141篇 |
1996年 | 111篇 |
1995年 | 115篇 |
1994年 | 82篇 |
1993年 | 72篇 |
1992年 | 98篇 |
1991年 | 97篇 |
1990年 | 88篇 |
1989年 | 69篇 |
1988年 | 56篇 |
1987年 | 54篇 |
1986年 | 39篇 |
1985年 | 45篇 |
1984年 | 23篇 |
1983年 | 23篇 |
1982年 | 21篇 |
1981年 | 13篇 |
1979年 | 20篇 |
1978年 | 16篇 |
1977年 | 19篇 |
1976年 | 15篇 |
1975年 | 15篇 |
1972年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
971.
972.
本文对甘肃宝积山盆地中侏罗世植物群地质时代及植物区系进行了探讨,共统计植物大化石18属53种,主要包括银杏纲10属24种,真蕨纲5属22种,苏铁纲1属3种,松柏纲1属2种,楔叶纲1属2种。该植物群在组成特征上表现为银杏类、真蕨类植物繁盛,其他植物类群相对贫乏。基于该植物群特征与国内其他植物群的对比,提出其地质时代为中侏罗世Aalenian期–Bajocian期。通过哈曼、欧式距离、罗杰斯–塔尼莫特和索卡尔–施尼斯4种方法对宝积山盆地及中国北方其余11个中侏罗世植物群进行系统聚类分析,在此基础上进一步划分了中国北方植物区系。通过计算属、种相似性系数,探讨宝积山邻近植物区系间的亲缘关系,结果表明宝积山植物区系与同属西北地区的华亭植物区系关系较为亲近。 相似文献
973.
G A Gao D X Zhu X Tao J Zheng A Scharfman G Lamblin Y W Shing K K Han 《The International journal of biochemistry》1989,21(4):391-399
1. Colony-stimulating factor (CSF-1) was isolated from a large volume of fresh normal human urine by 5 steps of purification and enrichment. 2. The purification factor is 100,000 fold and the purified compound exhibits a 2.16 x 10(7) U/mg of protein sp. act. 3. The isolated CSF-1 is a sialoglycoprotein with 41.5% of carbohydrate. The almost complete removal of this carbohydrate moiety (up to 91%) was achieved by incubation with trifluoromethane sulfonic acid. 4. The deglycosylated CSF-1 (DG-CSF-1) possesses an apparent Mr 38,000 compared to native CSF-1 with an initial Mr 57,000 (Goa et al., 1988). 5. The features of the interaction of radio-iodinated [125I]CSF-1 with single cell suspensions from various human tissues (bone marrow, spleen, blood, peritoneal cavity, alveolar lavage, lymph node and thymus), were studied. 6. The binding activity of peritoneal macrophages was the highest among the cells examined and erythrocytes, thymus and blood granulocytes showed no CSF-1 binding. 7. On incubation with [125I]CSF-1 at 0 degrees C, cellular binding of [125I]CSF-1 reached a stable maximum within 16 hr. This is in contrast to the association behaviour at higher temperature. 8. At 37 degrees C, cellular associated [125I]CSF-1 levels reached, within 90 min, an unstable maximum which was up to 10 times less than that occurring under the same conditions at 0 degree C. From the Scatchard plot analysis, we obtained the affinity constant and the number of receptor(s). 9. The binding site is sensitive to trypsin. 10. The receptor alone, (labelled by cross-linking to [125I]CSF-1 with di-succinylimidyl-suberate), is a polypeptide with an approx. Mr 110,000. 11. Our results showed that the receptor of CSF-1 is a tyrosin-kinase. 相似文献
974.
Jia Li Chenghui Yan Yilong Wang Can Chen Haibo Yu Dan Liu Kai Huang Yaling Han 《Cell death & disease》2022,13(4)
Pathological cardiac hypertrophy is a process of abnormal remodeling of cardiomyocytes in response to pressure overload or other stress stimuli, resulting in myocardial injury, which is a major risk factor for heart failure, leading to increased morbidity and mortality. General control nonrepressed protein 5 (GCN5)/lysine acetyltransferase 2 A, a member of the histone acetyltransferase and lysine acetyltransferase families, regulates a variety of physiological and pathological events. However, the function of GCN5 in pathological cardiac hypertrophy remains unclear. This study aimed to explore the role of GCN5 in the development of pathological cardiac hypertrophy. GCN5 expression was increased in isolated neonatal rat cardiomyocytes (NRCMs) and mouse hearts of a hypertrophic mouse model. GCN5 overexpression aggravated the cardiac hypertrophy triggered by transverse aortic constriction surgery. In contrast, inhibition of GCN5 impairs the development of pathological cardiac hypertrophy. Similar results were obtained upon stimulation of NRCMs (having GCN5 overexpressed or knocked down) with phenylephrine. Mechanistically, our results indicate that GCN5 exacerbates cardiac hypertrophy via excessive activation of the transforming growth factor β-activated kinase 1 (TAK1)-c-Jun N-terminal kinase (JNK)/p38 signaling pathway. Using a TAK1-specific inhibitor in rescue experiments confirmed that the activation of TAK1 is essential for GCN5-mediated cardiac hypertrophy. In summary, the current study elucidated the role of GCN5 in promotion of cardiac hypertrophy, thereby implying it to be a potential target for treatment.Subject terms: Heart failure, Cell signalling 相似文献
975.
Pierre-Yves Jean-Charles Vishwaesh Rajiv Subhodeep Sarker Sangoh Han Yushi Bai Ali Masoudi Sudha K. Shenoy 《The Journal of biological chemistry》2022,298(5)
Arrestins and their yeast homologs, arrestin-related trafficking adaptors (ARTs), share a stretch of 29 amino acids called the ART motif. However, the functionality of that motif is unknown. We now report that deleting this motif prevents agonist-induced ubiquitination of β-arrestin2 (β-arr2) and blocks its association with activated G protein–coupled receptors (GPCRs). Within the ART motif, we have identified a conserved phenylalanine residue, Phe116, that is critical for the formation of β-arr2–GPCR complexes. β-arr2 Phe116Ala mutant has negligible effect on blunting β2-adrenergic receptor–induced cAMP generation unlike β-arr2, which promotes rapid desensitization. Furthermore, available structures for inactive and inositol hexakisphosphate 6–activated forms of bovine β-arr2 revealed that Phe116 is ensconced in a hydrophobic pocket, whereas the adjacent Phe117 and Phe118 residues are not. Mutagenesis of Phe117 and Phe118, but not Phe116, preserves GPCR interaction of β-arr2. Surprisingly, Phe116 is dispensable for the association of β-arr2 with its non-GPCR partners. β-arr2 Phe116Ala mutant presents a significantly reduced protein half-life compared with β-arr2 and undergoes constitutive Lys-48-linked polyubiquitination, which tags proteins for proteasomal degradation. We also found that Phe116 is critical for agonist-dependent β-arr2 ubiquitination with Lys-63-polyubiquitin linkages that are known mediators of protein scaffolding and signal transduction. Finally, we have shown that β-arr2 Phe116Ala interaction with activated β2-adrenergic receptor can be rescued with an in-frame fusion of ubiquitin. Taken together, we conclude that Phe116 preserves structural stability of β-arr2, regulates the formation of β-arr2–GPCR complexes that inhibit G protein signaling, and promotes subsequent ubiquitin-dependent β-arr2 localization and trafficking. 相似文献
976.
977.
Ying Wang Yunjing Zhang Xinwan Su Qiongzi Qiu Yuan Yuan Chunhua Weng Sailan Zou Yan Tian Weidong Han Pengyuan Liu Xingyi Guo Jianhua Mao Xianghui Fu Ping Wang Weiqiang Lin 《International journal of biological sciences》2022,18(4):1491
Clear cell renal cell carcinoma (ccRCC) is a primary kidney cancer with high aggressive phenotype and extremely poor prognosis. Accumulating evidence suggests that circular RNAs (circRNAs) play pivotal roles in the occurrence and development of various human cancers. However, the expression, clinical significance and regulatory role of circRNAs in ccRCC remain largely unclear. Here we report that circDVL1 to be reduced in the serums and tissues from ccRCC patients, and to negatively correlate with ccRCC malignant features. Overexpression of circDVL1 inhibits proliferation, induces G1/S arrest, triggers apoptosis, and reduces migration and invasion in different ccRCC cells in vitro. Correspondingly, circDVL1 overexpression suppresses ccRCC tumorigenicity in a mouse xenograft model. Mechanistically, circDVL1 serves as a sponge for oncogenic miR-412-3p, thereby preventing miR-412-3p-mediated repression of its target protocadherin 7 (PCDH7) in ccRCC cells. Collectively, our results demonstrate that circDVL1 exerts tumor-suppressive function during ccRCC progression through circDVL1/miR-412-3p/PCDH7 axis, and suggest that circDVL1 could be a novel diagnostic and prognositc marker and therapeutic target for ccRCC. 相似文献
978.
Fei Liu Qianying Han Ting Zhang Fen Chang Jingcheng Deng Xiaotian Huang Weiping Wang Yongjie Xu Qin Li Luzheng Xu Bo Zhang Wentong Li Li Li Yanrong Su Yang Li Genze Shao 《International journal of biological sciences》2022,18(4):1434
BRCA1 is frequently down-regulated in breast cancer, the underlying mechanism is unclear. Here we identified DCAF8L1, an X-linked gene product, as a DDB1-Cullin associated Factor (DCAF) for CUL4 E3 ligases to target BRCA1 and BARD1 for proteasomal degradation. Forced expression of DCAF8L1 caused reduction of BRCA1 and BARD1, and impaired DNA damage repair function, conferring increased sensitivity to irradiation and DNA damaging agents, as well as Olaparib, a PARPi anticancer drug; while depletion of DCAF8L1 restored BRCA1 and suppressed the growth of its xenograft tumors. Furthermore, the expression of DCAF8L1 was induced in human H9 ES cells during transition from primed to naïve state when Xi chromosome was reactivated. Aberrant expression of DCAF8L1 was observed in human breast fibroadenoma and breast cancer. These findings suggest that CRL4DCAF8L1 is an important E3 ligase that may participate in the development of breast cancer, probably through regulating the stability of BRCA1 and BARD1 tumor suppressor, linking BRCA1 and X chromosome inactivation to breast carcinogenesis. 相似文献
979.
Jin Zhao Jiaoshan Chen Congcong Wang Yajie Liu Minchao Li Yanjun Li Ruiting Li Zirong Han Junjian Wang Ling Chen Yuelong Shu Genhong Cheng Caijun Sun 《PLoS pathogens》2022,18(3)
Tryptophan (Trp) metabolism through the kynurenine pathway (KP) is well known to play a critical function in cancer, autoimmune and neurodegenerative diseases. However, its role in host-pathogen interactions has not been characterized yet. Herein, we identified that kynurenine-3-monooxygenase (KMO), a key rate-limiting enzyme in the KP, and quinolinic acid (QUIN), a key enzymatic product of KMO enzyme, exerted a novel antiviral function against a broad range of viruses. Mechanistically, QUIN induced the production of type I interferon (IFN-I) via activating the N-methyl-d-aspartate receptor (NMDAR) and Ca2+ influx to activate Calcium/calmodulin-dependent protein kinase II (CaMKII)/interferon regulatory factor 3 (IRF3). Importantly, QUIN treatment effectively inhibited viral infections and alleviated disease progression in mice. Furthermore, kmo-/- mice were vulnerable to pathogenic viral challenge with severe clinical symptoms. Collectively, our results demonstrated that KMO and its enzymatic product QUIN were potential therapeutics against emerging pathogenic viruses. 相似文献
980.